Cite
HARVARD Citation
Zittan, E. et al. (2021). Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease. Clinical and translational gastroenterology. 12 (10), pp. e00401-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zittan, E. et al. (2021). Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease. Clinical and translational gastroenterology. 12 (10), pp. e00401-. [Online].